tsi
Ipsen buys Syntaxin
July 16, 2013Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi
French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
